Inventor

BELL STANLEY C

US38 patents

⚠️ This page may combine multiple inventors who share the name “BELL STANLEY C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BELL STANLEY C

AMERICAN HOME PROD

Process for the production of 2,6-diaminobenzonitrile derivatives

Antiinflammatory 5H-tetrazolo (5,1-c)(1,4)benzodiazepine derivatives

2-Guanyl-4-(substituted phenyl) thiazole derivatives

Leucotriene antagonists

Benzo-fused and heterocyclic fused imidazole anti-ulcer agents

1,3-Dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one, substituted diamino acetate esters and their acid salts

α-[(Alkylamino)-methyl]-β-aryloxy-benzeneethanols exhibiting antiarrhythmic activity

1-Alkyl-4-amino-3-(3-aminotriazolo)-1,8 naphthyridine-2-ones

Benzyl-tetrahydro-2,4-dihydroxy-1,6-naphthyridine-3 carboxylic acid type antiallergy agents

Antiviral thiazolo [5,4-b] pyridine compounds

Antiviral imidazo- and triazolo-pyridines

3-Hydroxy-3-substituted phenylthiazolo[2,3-b]quinazoline-2-alkanoic acids and their lactones

3-Substituted phenylthiazolo[3&#39;2&#39;:1,2]imidazo[4,5-b]pyridine-2-alkanoic acids

1-Substituted-6-(2-substituted aminoethoxy)xanthen-9-ones

4-Hydroxy-4-phenyl-2,3-cycloalkylimino-2-thiazolidinealkylcarboxylic acid lactones

Process for preparing α-[(alkylamino)methyl]-β-aryloxy-benzeneethanols

ONCONOVA THERAPEUTICS INC

Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders

Processes for the preparation of 1,5-diarylpyrazoles

Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles

Alkyne ketones

Processes for the preparation of substituted isoxazoles and 2-isoxazolines

Processes for the preparation of substituted isoxazoles and 2-isoxazolines

UNIV TEMPLE

Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders

N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof

Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders

Alpha, beta-unsaturated sulfoxides for treating proliferative disorders

ORTHO PHARMA CORP

Substituted 5,6-dialkoxyquinazoline derivatives

5,6-dialkoxy-4-imino-2(1H)quinazolinone derivatives

Substituted quinazolinediones

4-alkyl-5,6-methylenedioxy-2-1[H]-quinazolinones useful as cardiotonic agents

ALTEON INC

Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds

Method for treating fibrotic diseases or other indications IIC

Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds

BELL STANLEY C

Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones

Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions

MANIAR MANOJ

Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones

REDDY E PREMKUMAR

Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones

REDDY M V RAMANA

Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis

3-Substituted phenylthiazolo[3'2':1,2]imidazo[4,5-b]pyridine-2-alkanoic acids